US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.530
  • +0.580+19.66%
Close Aug 9 16:00 ET
  • 3.600
  • +0.070+1.98%
Post 20:02 ET
370.03MMarket Cap-1096P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
20.17%65.39M
13.46%51.94M
76.55%234.04M
39.82%69.8M
95.68%56.78M
91.81%54.41M
81.20%45.77M
70.40%132.57M
92.37%49.92M
46.95%29.02M
Operating revenue
20.17%65.39M
13.46%51.94M
76.55%234.04M
39.82%69.8M
95.68%56.78M
91.81%54.41M
81.20%45.77M
70.40%132.57M
92.37%49.92M
46.95%29.02M
Cost of revenue
0.16%17.64M
19.41%14.91M
43.93%74.36M
-25.70%17.47M
80.82%19.41M
84.89%17.61M
58.20%12.49M
120.70%51.67M
198.38%23.52M
82.40%10.74M
Gross profit
29.75%47.75M
11.23%37.03M
97.38%159.68M
98.16%52.33M
104.40%37.36M
95.31%36.81M
91.66%33.29M
48.74%80.9M
46.14%26.41M
31.89%18.28M
Operating expense
-11.68%82.27M
4.82%83.85M
8.20%382.01M
4.68%105.75M
-13.60%82.74M
21.47%93.15M
0.51%80M
7.29%353.07M
26.80%101.03M
10.60%95.76M
Selling and administrative expenses
-11.43%65.34M
11.30%68.91M
33.02%292.24M
31.32%84.3M
4.62%67.73M
57.53%73.77M
40.92%61.92M
10.50%219.7M
30.20%64.19M
25.05%64.74M
-Selling and marketing expense
104.78%123K
----
38.41%253.42M
----
----
---2.57M
----
--183.1M
----
----
-General and administrative expense
-14.57%65.22M
----
6.06%38.81M
-42.23%-169.13M
4.62%67.73M
63.03%76.34M
----
--36.6M
---118.91M
25.05%64.74M
Research and development costs
-9.77%15.9M
-17.90%14.39M
-21.60%79.41M
4.22%20.37M
-49.97%13.06M
-29.26%17.62M
-42.95%17.53M
-12.88%101.29M
-33.69%19.54M
-13.26%26.1M
Depreciation amortization depletion
-41.49%1.03M
0.00%545K
-67.70%10.36M
-93.70%1.09M
-60.33%1.95M
-64.47%1.76M
-88.92%545K
129.38%32.09M
1,809.27%17.3M
4.37%4.92M
-Depreciation and amortization
-41.49%1.03M
0.00%545K
-67.70%10.36M
-93.70%1.09M
-60.33%1.95M
-64.47%1.76M
-88.92%545K
129.38%32.09M
1,809.27%17.3M
4.37%4.92M
Operating profit
38.74%-34.52M
-0.25%-46.83M
18.31%-222.34M
28.41%-53.43M
41.43%-45.38M
2.58%-56.35M
24.93%-46.71M
0.91%-272.17M
-21.13%-74.62M
-6.55%-77.48M
Net non-operating interest income expense
-104.92%-2.5M
-48.00%-2.26M
47.59%-6.07M
-172.40%-1.96M
76.36%-1.36M
62.52%-1.22M
17.68%-1.53M
-95.13%-11.58M
52.00%-721K
-286.82%-5.75M
Non-operating interest income
0.98%3.18M
0.88%3M
171.62%13.29M
13.30%3.43M
220.43%3.73M
408.56%3.15M
3,807.89%2.97M
1,351.34%4.89M
4,169.01%3.03M
1,286.90%1.17M
Non-operating interest expense
30.01%5.68M
16.88%5.26M
17.49%19.36M
43.87%5.4M
-26.37%5.09M
12.75%4.37M
132.88%4.5M
162.62%16.47M
138.53%3.75M
340.29%6.92M
Other net income (expense)
24.37%-453K
-87.18%-438K
-32.39%-95.28M
99.56%-310K
-12,335.54%-94.14M
-77.22%-599K
12.03%-234K
-10,210.89%-71.97M
-882,712.50%-70.61M
-356.02%-757K
Special income (charges)
----
----
-35.33%-94.44M
99.24%-528K
---93.91M
----
----
---69.79M
---69.79M
--0
-Less：Restructuring and merger&acquisition
----
----
--1.26M
--528K
--732K
----
----
--0
--0
--0
-Less:Impairment of capital assets
----
----
33.52%93.18M
--0
--93.18M
----
----
--69.79M
--69.79M
--0
Other non- operating income (expenses)
24.37%-453K
-87.18%-438K
61.58%-838K
126.59%218K
70.54%-223K
-77.22%-599K
12.03%-234K
-212.46%-2.18M
-811.11%-820K
-418.49%-757K
Income before tax
35.58%-37.47M
-2.17%-49.53M
9.01%-323.69M
61.84%-55.7M
-67.72%-140.88M
5.32%-58.17M
24.67%-48.47M
-26.45%-355.72M
-131.31%-145.95M
-12.93%-83.99M
Income tax
101.56%1K
-57.14%300K
0
-57.14%300K
-119.57%-64K
700K
0
700K
Net income
44.28%-37.47M
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
Net income continuous Operations
35.51%-37.47M
-2.17%-49.53M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
5.93%-58.1M
24.67%-48.47M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
Net income discontinuous operations
99.96%-4K
67.97%-3.63M
----
----
----
---9.15M
---11.32M
----
----
----
Minority interest income
Net income attributable to the parent company
44.28%-37.47M
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
44.28%-37.47M
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
Basic earnings per share
55.00%-0.36
21.62%-0.58
21.84%-3.83
65.38%-0.63
-39.32%-1.63
9.09%-0.8
21.28%-0.74
-17.51%-4.9
-95.70%-1.82
-6.36%-1.17
Diluted earnings per share
55.00%-0.36
21.62%-0.58
21.84%-3.83
65.38%-0.63
-39.32%-1.63
9.09%-0.8
21.28%-0.74
-17.51%-4.9
-95.70%-1.82
-6.36%-1.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 20.17%65.39M13.46%51.94M76.55%234.04M39.82%69.8M95.68%56.78M91.81%54.41M81.20%45.77M70.40%132.57M92.37%49.92M46.95%29.02M
Operating revenue 20.17%65.39M13.46%51.94M76.55%234.04M39.82%69.8M95.68%56.78M91.81%54.41M81.20%45.77M70.40%132.57M92.37%49.92M46.95%29.02M
Cost of revenue 0.16%17.64M19.41%14.91M43.93%74.36M-25.70%17.47M80.82%19.41M84.89%17.61M58.20%12.49M120.70%51.67M198.38%23.52M82.40%10.74M
Gross profit 29.75%47.75M11.23%37.03M97.38%159.68M98.16%52.33M104.40%37.36M95.31%36.81M91.66%33.29M48.74%80.9M46.14%26.41M31.89%18.28M
Operating expense -11.68%82.27M4.82%83.85M8.20%382.01M4.68%105.75M-13.60%82.74M21.47%93.15M0.51%80M7.29%353.07M26.80%101.03M10.60%95.76M
Selling and administrative expenses -11.43%65.34M11.30%68.91M33.02%292.24M31.32%84.3M4.62%67.73M57.53%73.77M40.92%61.92M10.50%219.7M30.20%64.19M25.05%64.74M
-Selling and marketing expense 104.78%123K----38.41%253.42M-----------2.57M------183.1M--------
-General and administrative expense -14.57%65.22M----6.06%38.81M-42.23%-169.13M4.62%67.73M63.03%76.34M------36.6M---118.91M25.05%64.74M
Research and development costs -9.77%15.9M-17.90%14.39M-21.60%79.41M4.22%20.37M-49.97%13.06M-29.26%17.62M-42.95%17.53M-12.88%101.29M-33.69%19.54M-13.26%26.1M
Depreciation amortization depletion -41.49%1.03M0.00%545K-67.70%10.36M-93.70%1.09M-60.33%1.95M-64.47%1.76M-88.92%545K129.38%32.09M1,809.27%17.3M4.37%4.92M
-Depreciation and amortization -41.49%1.03M0.00%545K-67.70%10.36M-93.70%1.09M-60.33%1.95M-64.47%1.76M-88.92%545K129.38%32.09M1,809.27%17.3M4.37%4.92M
Operating profit 38.74%-34.52M-0.25%-46.83M18.31%-222.34M28.41%-53.43M41.43%-45.38M2.58%-56.35M24.93%-46.71M0.91%-272.17M-21.13%-74.62M-6.55%-77.48M
Net non-operating interest income expense -104.92%-2.5M-48.00%-2.26M47.59%-6.07M-172.40%-1.96M76.36%-1.36M62.52%-1.22M17.68%-1.53M-95.13%-11.58M52.00%-721K-286.82%-5.75M
Non-operating interest income 0.98%3.18M0.88%3M171.62%13.29M13.30%3.43M220.43%3.73M408.56%3.15M3,807.89%2.97M1,351.34%4.89M4,169.01%3.03M1,286.90%1.17M
Non-operating interest expense 30.01%5.68M16.88%5.26M17.49%19.36M43.87%5.4M-26.37%5.09M12.75%4.37M132.88%4.5M162.62%16.47M138.53%3.75M340.29%6.92M
Other net income (expense) 24.37%-453K-87.18%-438K-32.39%-95.28M99.56%-310K-12,335.54%-94.14M-77.22%-599K12.03%-234K-10,210.89%-71.97M-882,712.50%-70.61M-356.02%-757K
Special income (charges) ---------35.33%-94.44M99.24%-528K---93.91M-----------69.79M---69.79M--0
-Less：Restructuring and merger&acquisition ----------1.26M--528K--732K----------0--0--0
-Less:Impairment of capital assets --------33.52%93.18M--0--93.18M----------69.79M--69.79M--0
Other non- operating income (expenses) 24.37%-453K-87.18%-438K61.58%-838K126.59%218K70.54%-223K-77.22%-599K12.03%-234K-212.46%-2.18M-811.11%-820K-418.49%-757K
Income before tax 35.58%-37.47M-2.17%-49.53M9.01%-323.69M61.84%-55.7M-67.72%-140.88M5.32%-58.17M24.67%-48.47M-26.45%-355.72M-131.31%-145.95M-12.93%-83.99M
Income tax 101.56%1K-57.14%300K0-57.14%300K-119.57%-64K700K0700K
Net income 44.28%-37.47M11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M
Net income continuous Operations 35.51%-37.47M-2.17%-49.53M9.10%-323.99M61.84%-55.7M-66.69%-141.18M5.93%-58.1M24.67%-48.47M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M
Net income discontinuous operations 99.96%-4K67.97%-3.63M---------------9.15M---11.32M------------
Minority interest income
Net income attributable to the parent company 44.28%-37.47M11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 44.28%-37.47M11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M
Basic earnings per share 55.00%-0.3621.62%-0.5821.84%-3.8365.38%-0.63-39.32%-1.639.09%-0.821.28%-0.74-17.51%-4.9-95.70%-1.82-6.36%-1.17
Diluted earnings per share 55.00%-0.3621.62%-0.5821.84%-3.8365.38%-0.63-39.32%-1.639.09%-0.821.28%-0.74-17.51%-4.9-95.70%-1.82-6.36%-1.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.29%